Klein Uwe 4
4 · Septerna, Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Septerna (SEPN) SVP Uwe Klein Receives 80,000-Share Award
What Happened
Uwe Klein, Senior Vice President, Biological Sciences at Septerna, was granted a derivative award on February 6, 2026 that covers 80,000 shares. The filing lists an acquisition price of $0.00 (total listed value $0), indicating a compensatory equity award (derivative securities) rather than an open-market purchase or sale.
Key Details
- Transaction date: February 6, 2026; Form 4 filed February 10, 2026 (filing date shown; no late-filing flag indicated in the report).
- Award: 80,000 derivative shares, acquisition price $0.00 (reported value $0).
- Vesting: 2/48 of the shares vest on March 1, 2026, then the remaining shares vest in 46 substantially equal monthly installments thereafter, subject to continuous service.
- Shares owned after the transaction: not specified in the filing.
- Other filing notes: Footnote describes the vesting schedule; Exhibit 24.2 (Substitute Power of Attorney) attached.
Context
This is a compensatory equity grant to an executive (not an open-market trade). The $0.00 price in the filing reflects how the award is reported; the award's economic or tax value depends on the award type (options, RSUs or similar) and plan terms. Such grants are common as part of executive compensation and do not by themselves indicate a buy/sell signal.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-02-06+80,000→ 80,000 totalExercise: $25.41Exp: 2036-02-05→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]2/48th of the shares subject to such option shall vest and become exercisable on March 1, 2026 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.